Amarin Corp Plc (AMRN)

[sstyles]

Teva has asked for an en banc hearing just like Amarin did. Teva has until Dec. 2nd to submit its filing for en banc. Will thet get it? Who knows. My point is that the longer GSK v. Teva gets dragged out the better for Amarin. Delays are our friend.

Now can Amarin execute and take advantage of such delay and an open USA market is another question. It's barely been a month since the GSK v. Teva ruling came out that shook up the entire generic / big pharma landscape. While this seems like an eternity to us that decision only came out Friday Oct. 2nd after being heard back in 2019.

The GSK v. Teva decision does not hurt us; rather it helps us. Thank Judge Newman.

Now can Amarin execute?